88918-84-7 Usage
Description
4-Amino-N-methylbenzenemethanesulfonamide hydrochloride is a chemical compound characterized by an aminobenzenesulfonamide structure with a methyl group and a hydrochloride salt. It is recognized for its antimicrobial properties and is being explored for its potential in cancer treatment.
Uses
Used in Pharmaceutical Industry:
4-Amino-N-methylbenzenemethanesulfonamide hydrochloride is used as an antibacterial agent for its ability to inhibit bacterial growth and protein synthesis, which is vital for bacterial survival.
Used in Oncology Research:
In the field of oncology, 4-Amino-N-methylbenzenemethanesulfonamide hydrochloride is used as a potential anticancer agent due to its demonstrated capacity to inhibit the growth of tumor cells, making it a subject of interest for further research and development in cancer therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 88918-84-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,8,9,1 and 8 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 88918-84:
(7*8)+(6*8)+(5*9)+(4*1)+(3*8)+(2*8)+(1*4)=197
197 % 10 = 7
So 88918-84-7 is a valid CAS Registry Number.
InChI:InChI=1/C8H12N2O2S.ClH/c1-10-13(11,12)6-7-2-4-8(9)5-3-7;/h2-5,10H,6,9H2,1H3;1H
88918-84-7Relevant articles and documents
HETEROCYCLIC COMPOUNDS
-
, (2008/06/13)
Indole derivatives of the general formula (I) are disclosed: where R1 is H or an alkyl or alkenyl group, R2 is H, or an alkyl, alkenyl, aryl, aralkyl or cycloalkyl group; R3 is H or an alkyl group; R4 and R5 are independently H or an alkyl or propenyl group or together form an aralkylidene group; and Alk is an optionally substituted alkylene chain; and their physiologically acceptable salts and solutes. These compounds are potentially useful for the treatment of migraine and may be formulated as pharmaceutical compositions in conventional manner. Various methods for the production of the compounds are disclosed including a Fischer-indole cyclization process